VANGUARD GROUP INC - ASTERIAS BIOTHERAPEUTICS INC ownership

ASTERIAS BIOTHERAPEUTICS INC's ticker is AST and the CUSIP is 04624N107. A total of 64 filers reported holding ASTERIAS BIOTHERAPEUTICS INC in Q3 2017. The put-call ratio across all filers is 2.67 and the average weighting 0.0%.

Quarter-by-quarter ownership
VANGUARD GROUP INC ownership history of ASTERIAS BIOTHERAPEUTICS INC
ValueSharesWeighting
Q4 2018$251,000
-84.1%
405,474
-66.6%
0.00%
Q3 2018$1,579,000
-3.6%
1,215,141
+0.1%
0.00%
Q2 2018$1,638,000
-13.1%
1,213,341
-6.7%
0.00%
Q1 2018$1,885,000
-2.5%
1,299,963
+51.3%
0.00%
Q4 2017$1,934,000
-32.1%
859,260
+2.6%
0.00%
Q3 2017$2,847,000
+8.6%
837,261
+13.4%
0.00%
Q2 2017$2,622,000
-6.2%
738,535
-10.2%
0.00%
Q1 2017$2,796,000
-15.1%
822,244
+14.9%
0.00%
Q4 2016$3,293,000
+19.1%
715,756
+9.7%
0.00%
Q3 2016$2,766,000
+134.2%
652,260
+32.5%
0.00%
Q2 2016$1,181,000
-44.1%
492,261
+9.6%
0.00%
Q1 2016$2,112,000
+19.2%
449,253
-0.3%
0.00%
Q4 2015$1,772,000
-99.0%
450,753
-91.9%
0.00%
-100.0%
Q3 2015$182,081,000
+5643.9%
5,586,232
+710.9%
0.01%
Q2 2015$3,170,000
-7.5%
688,932
+35.5%
0.00%
Q1 2015$3,427,000508,4660.00%
Other shareholders
ASTERIAS BIOTHERAPEUTICS INC shareholders Q3 2017
NameSharesValueWeighting ↓
BROADWOOD CAPITAL INC 5,292,156$11,907,0001.66%
Northeast Financial Consultants Inc 732,265$1,647,0000.55%
AJ WEALTH STRATEGIES, LLC 29,624$67,0000.02%
Family Management Corp 10,424$23,0000.02%
Virtu Financial LLC 71,588$161,0000.01%
Poehling Capital Management, INC. 2,802$6,0000.01%
Founders Capital Management 2,000$5,0000.00%
BRIDGEWAY CAPITAL MANAGEMENT, LLC 148,054$333,0000.00%
WEDBUSH SECURITIES INC 11,000$25,0000.00%
THRIVENT FINANCIAL FOR LUTHERANS 298,303$671,0000.00%
View complete list of ASTERIAS BIOTHERAPEUTICS INC shareholders